Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood
NCT02839902
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperlipidemia
Interventions
DRUG:
TAK-085
OTHER:
Not treated with omega-3-acid ethyl esters
Sponsor
Takeda